Jose S, Bollinger J, Geller G, Greene J, Henry LM, Hutler B, Juengst ET, Kahn J, Mastroianni A, Mooney G, White A, Wilbanks R, Mathews D. Blurring Boundaries: A Proposed Research Agenda for Ethical, Legal, Social, and Historical Studies at the Intersection of Infectious and Genetic Disease. Journal of Law, Medicine, and Ethics. 2024. (in-press)
Jose S, Geller G, Bollinger J, Mathews D, Kahn J, Garibaldi B. The Ethics of Using COVID-19 Host Genomic Information for Clinical and Public Health Decision-making during the Pandemic: A Survey of US Health Professionals. Human Genetics and Genomics Advances. 2023; 5(1), 100255.
Linder JE, Tao R, Chung WK, Kiryluk K, Liu C, Weng C, Connolly JJ, Hakonarson H, Harr M, Leppig KA, Jarvik GP, Veenstra DL, Aufox S, Chisholm RL, Gordon AS, Hoell C, Rasmussen-Torvik LJ, Smith ME, Holm IA, Miller EM, Prows CA, Elskeally O, Kullo IJ, Lee C, Jose S, Manolio TA, Rowley R, Padi-Adjirackor NA, Wilmayani NK, City B, Wei WQ, Wiesner GL, Rahm AK, Williams JL, Williams MS, Peterson JF. Prospective, multi-site study of healthcare utilization after actionable monogenic findings from clinical sequencing. American Journal of Human Genetics. 2023; 110(11), 1950-1958.
eMERGE Consortium [including Jose S]. Lessons learned from the eMERGE Network: balancing genomics in discovery and practice. Human Genetics and Genomics Advances. 2021; 2(1), 100018.
eMERGE Consortium [including Jose S]. Harmonizing Clinical Sequencing and Interpretation for the eMERGE III Network. American Journal of Human Genetics. 2019; 105(3), 588.
Stremska, ME, Dai C, Venkatadri R, Wang H, Sabapathy V, Kumar G, Jose S, Mohammad S, Sung SJ, Fu SM, Sharma R. IL233, an IL-2-IL-33 Hybrid Cytokine Induces Prolonged Remission of Mouse Lupus Nephritis by Targeting Treg Cells as a Single Therapeutic Agent. Journal of Autoimmunity. 2019; 102, 133–141.
Kullo IJ, [and 26 others, including Jose S]. The Return of Actionable Variants Empirical (RAVE) Study, a Mayo Clinic Genomic Medicine Implementation Study: Design and Initial Results. Mayo Clinic Proceedings. 2018; 93(11), 1600-1610.
Stremska ME, Jose S, Sabapathy V, Huang L, Bajwa A, Kinsey GR, Sharma PR, Mohammad S, Rosin DL, Okusa MD, Sharma R. IL233, a Novel IL-2 and IL-33 Hybrid Cytokine, Ameliorates Renal Injury. Journal of the American Society of Nephrology. 2017; 28(9), 2681-2693.